Article info
Viewpoint
Proposal for a new nomenclature of disease-modifying antirheumatic drugs
- Correspondence to Professor Josef S Smolen, Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18-20, Vienna A-1090, Austria; josef.smolen{at}wienkav.at
Citation
Proposal for a new nomenclature of disease-modifying antirheumatic drugs
Publication history
- Received July 20, 2013
- Revised August 26, 2013
- Accepted September 8, 2013
- First published September 26, 2013.
Online issue publication
December 04, 2013
Article Versions
- Previous version (26 September 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions